Form 8-K - Current report:
SEC Accession No. 0001104659-24-056424
Filing Date
2024-05-02
Accepted
2024-05-02 16:39:04
Documents
13
Period of Report
2024-04-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2413348d1_8k.htm   iXBRL 8-K 24420
  Complete submission text file 0001104659-24-056424.txt   195120

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20240426.xsd EX-101.SCH 3006
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20240426_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20240426_pre.xml EX-101.PRE 22353
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2413348d1_8k_htm.xml XML 3584
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

EIN.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35737 | Film No.: 24909157
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)